Pharmasset, Idenix vets lead HBV company Antios to $25M series A

By Mark Zipkin | Nov 30, 2018 | 6:30 PM GMT

Founded by former executives of HCV companies that scored big exits, Antios Therapeutics Inc. (Atlanta, Ga.) raised a $25 million series